Maura Gillison L MD, PhD

Maura Gillison L MD, PhD
ProfessorCollege of Medicinegillison.3@osu.edu
690 Tzagournis Med Res Facility 420 W 12th Avenue Columbus Ohio 43210
Phone:614-247-4589Fax: (614) 688-4245
  • Cancer Control

General Research Interest

Head and neck cancer, human papillomavirus, infectious-disease tumor associations

Research Description

The principal focus of the Gillison laboratory is to investigate the role of human papillomavirus infection in head and neck malignancies, from cohort studies of oral HPV infection to genetic indicators of response to chemoradiotherapy.

Transinstitutional Work

The Gillison laboratory has several ongoing collaborations with the Centers for Disease Control, USA, the National Cancer Institute, USA, and the International Agency for Research on Cancer. Dr. Gillison is also a member of the head and neck steering committees of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Current Publications

  • Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison MLInstitutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer.J Clin Oncol in press 12/8/2014
  • Beachler DC, Sugar EA, Margolick JB, Weber KM, Strickler HD, Wiley DJ, Cranston RD, Burk RD, Minkoff H, Reddy S, Xiao W, Guo Y, Gillison ML, D'Souza GRisk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults.Am J Epidemiol in press 12/4/2014
  • Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QTRandomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity.J Clin Oncol in press 11/3/2014
  • Fakhry C, Gillison ML, D'Souza GTobacco use and oral HPV-16 infection.JAMA 312 1465-7 10/8/2014
  • Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes MHead and neck cancers, version 2.2014.J Natl Compr Canc Netw 12 1454-87 10/1/2014
  • Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QTp16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma.J Clin Oncol in press 9/29/2014
  • Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RSRandomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.J Clin Oncol 32 2940-50 9/20/2014
  • Weber RS, Galvin JM, Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RSRandomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522.J Clin Oncol in press 8/25/2014
  • Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Khuntia D, Straube W, Zhang Q, Ang K, Rotman MPostoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234.J Clin Oncol 32 2486-95 8/10/2014
  • Gillison ML, Posner MR, D'Souza G, Gross ND, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber JOral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners.J Clin Oncol 32 2408-15 8/10/2014
  • Chaturvedi AK, Graubard BI, Pickard RK, Xiao W, Gillison MLHigh-Risk Oral Human Papillomavirus Load in the US Population, National Health and Nutrition Examination Survey 2009-2010.J Infect Dis 210 441-7 8/1/2014
  • Brennan P, Holcatova I, Jayaprakash V, Kelsey K, Kjaerheim K, Koifman S, La Vecchia C, Lagiou P, Lazarus P, Levi F, Ramroth H, Richiardi L, Rudnai P, Schantz S, Schwartz SM, Shangina O, Simonato L, Smith E, Stucker I, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Thomson P, Vaughan TL, Wei Q, Winn DM, Wunsch-Filho V, Yu GP, Zhang ZF, Zheng T, Znaor A, Boffetta P, Chuang SC, Ghodrat M, Amy Lee YC, Hashibe M, Conway DI, Brenner DR, McMahon AD, Macpherson LM, Agudo A, Ahrens W, Bosetti C, Brenner H, Castellsague X, Chen C, Curado MP, Curioni OA, Dal Maso L, Daudt AW, de Gois Filho JF, D'Souza G, Edefonti V, Fabianova E, Fernandez L, Franceschi S, Gillison M, Hayes RB, Healy CM, Herrero R, Lissowska J, Luce D, Macfarlane TV, Mates D, Matos E, McClean M, Menezes AM, Menvielle G, Merletti F, Morgenstern H, Moysich K, Müller H, Muscat J, Olshan AF, Purdue MPEstimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries.Int J Cancer in press 7/4/2014
  • Fakhry C, Agrawal N, Califano J, Messing B, Liu J, Saunders J, Ha P, Coquia S, Hamper U, Gillison M, Blanco RThe use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers.Oral Oncol 50 640-5 7/1/2014
  • Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison MHuman Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma.J Clin Oncol in press 6/23/2014
  • Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ERPrevalence of cervical and oral human papillomavirus infections among US women.J Infect Dis 209 1739-43 6/1/2014
  • Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, Wikenheiser-Brokamp KA, Wise-Draper TM, Wells SI, Adams AKDEK promotes HPV-positive and -negative head and neck cancer cell proliferation.Oncogene in press 1 3/10/2014
  • Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi SEurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.Int J Cancer 134 497-507 2/1/2014
  • Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison MLGenome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res 24 185-99 2/1/2014
  • Blanco RG, Califano J, Messing B, Richmon J, Liu J, Quon H, Neuner G, Saunders J, Ha PK, Sheth S, Gillison M, Fakhry CTranscervical ultrasonography is feasible to visualize and evaluate base of tongue cancers.PLoS One 9 e87565 1/1/2014
  • Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012Comprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 7 H1-31 12/31/2013
  • Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Bosch FX, Albero G, Diaz M, de Sanjosé S, ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012Comprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 6 G1-31 12/30/2013
  • Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012, Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley MComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 5 F1-31 12/29/2013
  • Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison MLWorldwide trends in incidence rates for oral cavity and oropharyngeal cancers.J Clin Oncol 31 4550-9 12/20/2013
  • Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LAComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 8 I1-31 11/22/2013
  • Perez-Ordoñez B, Irish JC, Yu ES, Gillison MLHuman papillomavirus-16 associated adenocarcinoma NOS of base of tongue.Head Neck Pathol 7 268-73 9/1/2013
  • Pfister DG, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RSHead and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.J Natl Compr Canc Netw 11 917-23 8/1/2013
  • Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison MLNatural history of anal vs oral HPV infection in HIV-infected men and women.J Infect Dis 208 330-9 7/15/2013
  • Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML, Lingen MW, Xiao WLow etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.Oral Oncol 49 1-8 1/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu